Epstein Secrets

EFTA00130083 NMS LI S Toxicology Report Report Issued 08/22/2019 17:09 Phone email: PhD. F-ADFT, DADCC-TC, Laboratory Director To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: CONFIDENTIAL Patient Name FT19-03508 M19-019432

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 nglmL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 nglmL NA-FUBIM 0.20 ng/mL Rot. Limit Compound Rot. Limit NMS v.18.0 EFTA00130085 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER

2 ornagnmstabs.com Robert A. likldieberg, PhD, Fair; DABCC-TC, Laboratory lIrecior Toxicology Report Report issued 08/22/2019 17:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name FT19-03508 M19-019432 Patient ID

-PINACA 5-fluoro- EMB-PINACA 5-fluoro-MMB-PINACA 5-fluoro-NA-PIC 5-fluoro-QU-PINAC ADAMANTYL-FUBINACA ADMB-CHMINACA ADMB-FUBICA ADMB-FUBINACA AMB-CHMINACA Rot Limit 0.10 ng/mL 0.10 ng/mL 0.10 ng/mL 0.10 ng/mL 0.20 ng/mL 0.050 ng/rra. 0.10 ng/mL 0.10 ng/mL 0.20 ng/mL 0.10 ng/mL 1.0 ng/mL 1.0

19044-2208 Phone: Robert A. PAIddlebem. PhD. F-ABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08722/2019 17:09 To: 10074 New York Office of Chief Medical Examiner of Toxicology 0016 Positive Findings: Patient Name Patient ID Chain Age Not Given Gender Workorder Pago 1 of 2 CONFIDENTIAL FT19

ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 rig/mt. MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA•FUBIM 0.20 ng/mL NMS v.18.0 EFTA00063528 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMB

il: [email protected] Robert A. MIddleberg, PhD, PABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08/22/2019 17:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name FT19-03508 M19-019432 Patient ID

ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1 0 ng/mL ADMB-FUBICA 1.0 ngIrrL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 020 ng/mL NMS v.18.0 EFTA00049624 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMBE

labs.com CONFIDENTIAL t b)(S); (b)(?)(C) jo. F-ABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08/22/201917:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name Patient ID Chain FT19-03508 M19-0

L ADMB-CHMINACA 0.10 ng/ml MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/ml ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/ml AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/ml NMSv.18.0 Page 3243 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMBER:

Report Issued 08/22/2019 17:09 NMS Labs 200 Welsh Road, Horsham, PA 19044-2208 PhoneNaas: ( e-mail: DABCC-TC, Laboratory Director To: 10074 New York Office of Chief Medical Examiner Atha. Dopat i mot of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name Patient ID Chain Age Not Given

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/mL NMS v.18.0 EFTA00133089 EFTA00133090 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY RE